Targeting ketone body metabolism to treat fatty liver disease
Metabolic dysfunction-associated steatotic liver disease (MASLD) is a metabolic disorder marked by excessive accumulation of lipids within the liver. If untreated, this condition can progress to metabolic dysfunction-associated steatohepatitis (MASH), fibrosis, cirrhosis, and ultimately, hepatocellu...
Saved in:
Main Authors: | Sora Kwon (Author), Reshani Jeyaratnam (Author), Kyoung-Han Kim (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2024-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical significance of serum alanine aminotransferase and lifestyle intervention in children with nonalcoholic fatty liver disease
by: Kyoung Ah Kwon, et al.
Published: (2016) -
Fatty liver associated with metabolic derangement in patients with chronic kidney disease: A controlled attenuation parameter study
by: Chang-Yun Yoon, et al.
Published: (2017) -
Nootkatone, a Sesquiterpene Ketone From Alpiniae oxyphyllae Fructus, Ameliorates Metabolic-Associated Fatty Liver by Regulating AMPK and MAPK Signaling
by: Zhang Yong, et al.
Published: (2022) -
Genetic and metabolic factors: the perfect combination to treat metabolic associated fatty liver disease
by: Marica Meroni, et al.
Published: (2020) -
Cardiomyocyte-specific deficiency of ketone body metabolism promotes accelerated pathological remodeling
by: Rebecca C. Schugar, et al.
Published: (2014)